Also trades as: 0HRS.L (LSE) · $vol 3M · CVS.DE (XETRA) · $vol 0M

$93.26

-0.06 (-0.06%)

Weekly Expected Move ±5.7%

$85 $90 $96 $101 $107

NYSE · Healthcare · Medical - Healthcare Plans · Alpha Radar Strong Buy · Power 74 · $119.0B mcap · 1.27B float · 0.651% daily turnover · Short 46% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$402.1B +7.8% ▲

5Y CAGR: +8.4%

Gross Profit

$55.4B +7.7% ▲

5Y CAGR: +2.5%

Operating Income

$10.4B +21.9% ▲

5Y CAGR: -5.7%

Net Income

$1.8B -61.7% ▼

5Y CAGR: -24.4%

EPS (Diluted)

$1.39 -62.0% ▼

5Y CAGR: -23.9%

EBITDA

$9.9B -27.9% ▼

5Y CAGR: -10.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$292.1B	$322.5B	$357.8B	$372.8B	$402.1B
YoY Growth	+8.7%	+10.4%	+10.9%	+4.2%	+7.8%
Cost of Revenue	$240.0B	$268.0B	$303.3B	$321.4B	$346.7B
Gross Profit	$52.1B	$54.5B	$54.4B	$51.4B	$55.4B
Gross Margin	17.8%	16.9%	15.2%	13.8%	13.8%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$41.2B	$0
Operating Expenses	$38.8B	$46.5B	$40.7B	$42.9B	$45.0B
Operating Income	$13.3B	$8.0B	$13.7B	$8.5B	$10.4B
Operating Margin	4.6%	2.5%	3.8%	2.3%	2.6%
Interest Expense	$2.5B	$2.3B	$2.7B	$3.0B	$3.1B
Income Before Tax	$10.5B	$5.8B	$11.2B	$6.1B	$2.1B
Tax Expense	$2.5B	$1.5B	$2.8B	$1.6B	$408M
Net Income	$8.0B	$4.3B	$8.3B	$4.6B	$1.8B
Net Margin	2.7%	1.3%	2.3%	1.2%	0.4%
EPS (Diluted)	$5.95	$3.26	$6.47	$3.66	$1.39
EBITDA	$17.5B	$12.3B	$18.2B	$13.7B	$9.9B
Shares Outstanding	1.33B	1.32B	1.29B	1.26B	1.27B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$91.2B	$95.4B	$97.7B	$94.6B	$98.9B	$102.9B	$105.7B	$100.4B
Cost of Revenue	$77.9B	$82.9B	$84.8B	$80.2B	$85.3B	$89.1B	$92.1B	$84.8B
Gross Profit	$13.4B	$12.6B	$12.9B	$14.4B	$13.6B	$13.8B	$13.6B	$15.6B
Gross Margin	14.7%	13.2%	13.2%	15.2%	13.7%	13.4%	12.8%	15.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$0	$0	$0	$0	$0
Operating Expenses	$10.3B	$11.7B	$10.5B	$11.0B	$11.2B	$17.0B	$11.5B	$10.9B
Operating Income	$3.0B	$832M	$2.4B	$3.4B	$2.4B	-$3.2B	$2.1B	$4.7B
Operating Margin	3.3%	0.9%	2.4%	3.6%	2.4%	-3.1%	2.0%	4.7%
Interest Expense	$732M	$752M	$758M	$785M	$763M	$784M	$787M	$774M
Income Before Tax	$2.3B	$105M	$2.1B	$2.6B	$1.6B	-$3.5B	$1.4B	$3.9B
Tax Expense	$569M	$34M	$503M	$835M	$634M	$508M	-$1.6B	$995M
Net Income	$1.8B	$87M	$1.6B	$1.8B	$1.0B	-$4.0B	$2.9B	$2.9B
Net Margin	1.9%	0.1%	1.7%	1.9%	1.0%	-3.9%	2.8%	2.9%
EPS (Diluted)	$1.41	$0.07	$1.30	$1.41	$0.80	$-3.13	$2.30	$2.30
EBITDA	$4.2B	$2.0B	$4.0B	$4.6B	$3.6B	-$1.6B	$3.3B	$5.8B
Shares Outstanding	1.26B	1.26B	1.26B	1.26B	1.27B	1.27B	1.28B	1.28B

CVS NYSE